Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Morpholine dopamine agonists

Morpholine dopamine agonists

US Patent 7902188 · Granted Mar 8, 2011

Estimated economic value: $212,034,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SRPK1 inhibitors2025
Bicyclic-fused heteroaryl or aryl compounds2025
Splicing modulator antibody-drug conjugates and methods of use2024
Chemical compounds2024
1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular dis2024
Splicing modulator antibody-drug conjugates and methods of use2024
Certain pladienolide compounds and methods of use2024
Chemical compounds2023
Bicyclic-fused heteroaryl or aryl compounds2023
Certain aryl pladienolide compounds and methods of use2023
Oxepinopyrazole derivatives as inhibitors of P13-kinase activity2023
SRPK1 inhibitors2022